elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q28538326-2FE4C3A8-44EA-4271-9E5B-4F721821F695
Q28538326-2FE4C3A8-44EA-4271-9E5B-4F721821F695
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28538326-2FE4C3A8-44EA-4271-9E5B-4F721821F695
First line treatment response in patients with transmitted HIV drug resistance and well defined time point of HIV infection: updated results from the German HIV-1 seroconverter study
P2860
Q28538326-2FE4C3A8-44EA-4271-9E5B-4F721821F695
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28538326-2FE4C3A8-44EA-4271-9E5B-4F721821F695
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
055150435b3723ad18685278a589ff8e2ade556e
P2860
Class-sparing regimens for initial treatment of HIV-1 infection.